2C0O

Src family kinase Hck with bound inhibitor A-770041

Summary for 2C0O

• Entry DOI: 10.2210/pdb2c0o/pdb
• Related: 1AD5 1BU1 1QCF 2C0I 2C0T 2HCK 3HCK 4HCK 5HCK
• Descriptor: TYROSINE-PROTEIN KINASE HCK, N-(4-{1-[4-(4-ACETYLPIPERAZIN-1-YL)-TRANS-CYCLOHEXYL]-4-AMINO-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL}-2-METHOXYPHENYL)-1-METHYL-1H-INDOLE-2-CARBOXAMIDE, CALCIUM ION, ... (4 entities in total)
• Functional Keywords: tyrosine-protein kinase, transferase, atp-binding, kinase, lipoprotein, myristate, nucleotide-binding, palmitate, phosphorylation, sh2 domain, sh3 domain
• Biological source: HOMO SAPIENS (HUMAN)
• Total number of polymer chains: 2
• Total formula weight: 105324.07

Authors

Borhani, D.W.,Burchat, A.,Calderwood, D.J.,Hirst, G.C.,Li, B.,Loew, A. (deposition date: 2005-09-06, release date: 2006-09-20, Last modification date: 2024-10-23)

Primary citation

Burchat, A.,Borhani, D.W.,Calderwood, D.J.,Hirst, G.C.,Li, B.,Stachlewitz, R.F.
Discovery of A-770041, a Src-Family Selective Orally Active Lck Inhibitor that Prevents Organ Allograft Rejection.
Bioorg.Med.Chem.Lett., 16:118-, 2006

PubMed Abstract: We describe the identification, SAR, and pharmacology of the src-family selective lck inhibitor A-770041 that prolongs the survival of major histocompatibility mismatched allografts in models of solid organ transplant rejection for greater than 65 days.

PubMed: 16216497
DOI: 10.1016/J.BMCL.2005.09.039

Experimental method

X-RAY DIFFRACTION (2.85 Å)